MDxHealth SA
MDXH- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001872529
In the last 90 days, MDxHealth SA insiders filed 1 open-market purchase and 0 sales; 26 institutions reported holding it in 13F filings for Q2 2026, worth $6.79M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in MDxHealth SA as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +1 vs. Q1 2025
- Shares held
- 21.5M
- +303.2K (+1.4%) vs. Q1 2025
- Total value
- $47.6M
- +$17.5M (+58.2%) vs. Q1 2025
- New holders
- 3
- 3 more added
- Sold out
- 2
- 4 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDXH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $6.79M |
| Q1 2026 | 51 | $56.9M |
| Q4 2025 | 56 | $86.8M |
| Q3 2025 | 42 | $105.9M |
| Q2 2025 | 21 | $47.6M |
| Q1 2025 | 21 | $30.1M |
| Q4 2024 | 24 | $53.2M |
| Q3 2024 | 22 | $47.4M |
| Q2 2024 | 9 | $21.0M |
| Q1 2024 | 13 | $24.2M |
| Q4 2023 | 12 | $37.5M |
| Q3 2023 | 11 | $18.9M |
| Q2 2023 | 19 | $25.1M |
| Q1 2023 | 14 | $28.1M |
| Q4 2022 | 5 | $18.2M |
| Q3 2022 | 4 | $13.8M |
| Q2 2022 | 5 | $24.7M |
| Q1 2022 | 5 | $24.5M |
| Q4 2021 | 7 | $29.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding MDxHealth SA; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 29 | $64 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 72 | $159 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 200 | $442 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 286 | $632 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 764 | $1.69K | 0.00% | −2,000−72.4% | Reduced |
| UBS Group AG | 1,470 | $3.25K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 10,394 | $23.0K | 0.00% | 00.0% | Unchanged |
| Oppenheimer & Co Inc | 20,000 | $44.2K | 0.00% | 00.0% | Unchanged |
| Financial Advisory Service, Inc. | 22,625 | $50.0K | 0.00% | 00.0% | Unchanged |
| Castleview Partners, LLC | 32,594 | $72.0K | 0.05% | −1,182−3.5% | Reduced |
| Citadel Advisors LLC | 37,482 | $82.8K | 0.00% | +37,482 | New |
| BlackRock, Inc. | 85,518 | $189.0K | 0.00% | +85,518 | New |
| FreeGulliver LLC | 123,546 | $273.0K | 0.13% | +123,546 | New |
| Renaissance Technologies LLC | 145,273 | $321.1K | 0.00% | +23,073+18.9% | Added |
| Delta Investment Management, LLC | 173,100 | $382.6K | 0.07% | −17,000−8.9% | Reduced |
| Northern Trust Corp | 628,333 | $1.39M | 0.00% | +2,913+0.5% | Added |
| Perkins Capital Management Inc | 1,420,025 | $3.14M | 3.16% | +238,550+20.2% | Added |
| Samjo Management, LLC | 1,535,350 | $3.39M | 1.43% | −96,718−5.9% | Reduced |
| MVM Partners, LLC | 4,700,457 | $10.3M | 100.00% | 00.0% | Unchanged |
| AWM Investment Company, Inc. | 5,221,282 | $11.5M | 1.29% | 00.0% | Unchanged |
| Bleichroeder LP | 7,378,333 | $16.3M | 4.01% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −70,293−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −20,737−100.0% | Sold out |
| Credit Agricole S A | – | – | – | – | Not filed |